146 related articles for article (PubMed ID: 6271047)
1. Effect of subinhibitory concentrations of mecillinam on the serum susceptibility of Escherichia coli strains.
Taylor PW; Gaunt H; Unger FM
Antimicrob Agents Chemother; 1981 May; 19(5):786-8. PubMed ID: 6271047
[TBL] [Abstract][Full Text] [Related]
2. Mutational change of CTX-M-15 to CTX-M-127 resulting in mecillinam resistant Escherichia coli during pivmecillinam treatment of a patient.
Nielsen KL; Hansen KH; Nielsen JB; Knudsen JD; Schønning K; Frimodt-Møller N; Hertz FB; Jansåker F
Microbiologyopen; 2019 Dec; 8(12):e941. PubMed ID: 31573735
[TBL] [Abstract][Full Text] [Related]
3. [Antibacterial activity of mecillinam against E. coli isolated from urinary tract infections (author's transl)].
Shimizu Y
Jpn J Antibiot; 1981 Jul; 34(7):1087-91. PubMed ID: 6275141
[TBL] [Abstract][Full Text] [Related]
4. Studies on the effect of mecillinam upon Micrococcaceae and faecal streptococci under conditions simulating urinary tract infection.
Anderson JD; Adams MA; Wilson LC; Shepherd CA
J Antimicrob Chemother; 1976 Dec; 2(4):351-61. PubMed ID: 206530
[No Abstract] [Full Text] [Related]
5. Reversion of High-level Mecillinam Resistance to Susceptibility in Escherichia coli During Growth in Urine.
Thulin E; Thulin M; Andersson DI
EBioMedicine; 2017 Sep; 23():111-118. PubMed ID: 28855073
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility to mecillinam of Escherichia coli strains isolated from the urine of pregnant women.
Duployez C; Loiez C; Cattoen C; Descamps D; Wallet F; Vachée A;
Med Mal Infect; 2016 Dec; 46(8):436-441. PubMed ID: 27609597
[TBL] [Abstract][Full Text] [Related]
7. The influence of long-term treatment with mecillinam on fecal Escherichia coli.
Møller JK; Stenderup A
Scand J Infect Dis; 1984; 16(2):223-4. PubMed ID: 6330882
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.
O'Kelly F; Kavanagh S; Manecksha R; Thornhill J; Fennell JP
BMC Infect Dis; 2016 Nov; 16(1):620. PubMed ID: 27806687
[TBL] [Abstract][Full Text] [Related]
9. Pivmecillinam (selexid).
Drug Ther Bull; 1978 Dec; 16(26):103-4. PubMed ID: 214285
[No Abstract] [Full Text] [Related]
10. Pivmecillinam in treatment of Staphylococcus saprophyticus urinary tract infections.
Granlund M; Landgren E; Henning C
Scand J Infect Dis; 1983; 15(1):65-9. PubMed ID: 6302831
[TBL] [Abstract][Full Text] [Related]
11. Mecillinam resistance in Escherichia coli: dissociation of growth inhibition and morphologic change.
Barbour AG; Mayer LW; Spratt BG
J Infect Dis; 1981 Jan; 143(1):114-21. PubMed ID: 6260864
[TBL] [Abstract][Full Text] [Related]
12. Effects of subinhibitory amounts of ampicillin, amoxycillin and mecillinam on the adhesion of Escherichia coli bacteria to human urinary tract epithelial cells: a preliminary study.
Svanborg-Edén C; Sandberg T; Stenqvist K; Ahlstedt S
Infection; 1979; 7 Suppl 5():S452-5. PubMed ID: 229079
[TBL] [Abstract][Full Text] [Related]
13. [Effects of ampicillin and cefazolin combined with mecillinam (author's transl)].
Stille W; Bischof-Léger E; Helm EB
Arzneimittelforschung; 1978; 28(10):1661-4. PubMed ID: 226099
[TBL] [Abstract][Full Text] [Related]
14. Serum estriol level during treatment with pivmecillinam.
Kjer JJ
Acta Obstet Gynecol Scand; 1983; 62(2):153-4. PubMed ID: 6306983
[TBL] [Abstract][Full Text] [Related]
15. Emerging clinical role of pivmecillinam in the treatment of urinary tract infections caused by Extended Spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae.
Raja NS
Int J Clin Pract; 2019 Sep; 73(9):1-5. PubMed ID: 31243859
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of PBP1B and LpoB in
Thulin E; Andersson DI
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332059
[TBL] [Abstract][Full Text] [Related]
17. Results from a Prospective
Fuchs F; Hamprecht A
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917983
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to mecillinam and other antibiotics and serogroups of enterotoxigenic Escherichia coli from children in Addis Ababa.
Stintzing G; Jacobsen J
J Antimicrob Chemother; 1983 Nov; 12(5):469-74. PubMed ID: 6323370
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic sensitivity of enteropathogenic Escherichia coli to mecillinam, trimethoprim-sulfamethoxazole and other antibiotics.
Thorén A
Acta Pathol Microbiol Scand B; 1980 Oct; 88(5):265-8. PubMed ID: 6258383
[TBL] [Abstract][Full Text] [Related]
20. Synergistic and bactericidal activities of mecillinam, amoxicillin and clavulanic acid combinations against extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in 24-h time-kill experiments.
Skarp KP; Shams A; Montelin H; Lagerbäck P; Tängdén T
Int J Antimicrob Agents; 2019 Jan; 53(1):74-79. PubMed ID: 30236958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
